Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Curie.Bio
AddedFeb 13, 2024
UpdatedJun 28, 2026
Curie.Bio

Curie.Bio

Series B

Curie.Bio: A seed-stage venture firm specializing in drug-focused services for founders.

HQ
Boston, MA, US
Founded
2022
Overview
Compare
Employees
Website

Curie.Bio is a seed-stage venture capital firm founded with a mission to support founders in the drug development sector. The firm specializes in providing drug-focused services, aiming to accelerate the growth and success of early-stage biotech startups. Curie.Bio's vision is to empower entrepreneurs with the resources and expertise needed to bring innovative therapies to market, focusing on transformative medical advancements.

Notable affiliated individuals and investors include experienced professionals from the biotech and venture capital industries, although specific names are not provided. Key achievements of Curie.Bio include successfully funding and supporting multiple early-stage biotech companies, contributing to significant advancements in drug development. The overall impact of Curie.Bio is seen in its ability to foster innovation and drive progress in the biotech sector, ultimately improving patient outcomes and advancing medical science.

Curie.Bio - Similar Companies

Bioventure Partners logo

Bioventure Partners

Biotechonomy logo

Biotechonomy

Curi Bio logo

Curi Bio

curibio.com

Orchid BioVentures logo

Orchid BioVentures

curative ventures logo

curative ventures

Vibe Bio logo

Vibe Bio

vibebio.com

Pathway Bioventures logo

Pathway Bioventures

Inning One Ventures logo

Inning One Ventures

inning1.com

Aurion Biotech logo

Aurion Biotech

aurionbiotech.com

Saya Bio logo

Saya Bio

saya.bio

BioCurity Pharmaceuticals logo

BioCurity Pharmaceuticals

biocurity.com

Axial logo

Axial

axialvc.com

CuraFi logo

CuraFi

curafi.com

CuriMeta logo

CuriMeta

curimeta.com

Ventura BioMed Investors logo

Ventura BioMed Investors

ventura-biomed.com

Curie.Bio - Quick Facts

Who are Curie.Bio's competitors?

Companies similar to Curie.Bio include Bioventure Partners, Biotechonomy, Curi Bio and Orchid BioVentures.

When was Curie.Bio founded?

Curie.Bio was founded in 2022.

Where is Curie.Bio's headquarters located?

Curie.Bio's headquarters is located in Boston, MA, US.

How many employees does Curie.Bio have?

Curie.Bio has 26 employees as of Feb 4, 2024.

Curie.Bio - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • Americas
Revenue
  • Recurring
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Financial
  • SaaS
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 4 more industry codes
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified